ANG Lifesciences India Limited has announced the appointment of Mrs. Preeti Sarin as an Additional Independent Director to its Board of Directors. This appointment is effective from November 14, 2026, for a term of five consecutive years. The Board also considered and approved the unaudited financial results for the quarter and half-year ended September 30, 2026, along with the limited review report from the statutory auditors.
Boardroom Expansion
ANG Lifesciences India Limited has welcomed Mrs. Preeti Sarin to its Board of Directors as an Additional Independent Director. Her tenure will commence on November 14, 2026, and is set to last for a period of five years, concluding on November 13, 2031, subject to shareholder approval. Mrs. Sarin brings a professional background with a Bachelor of Business Administration degree and over 10 years of experience in business administration and management.
Financial Results Approved
In addition to the board appointment, the company’s Board of Directors, during its meeting held on November 14, 2026, reviewed and approved the unaudited financial results for the quarter and half-year ended September 30, 2026. This included both standalone and consolidated statements, prepared as per Indian Accounting Standards. A limited review report from the appointed statutory auditors, M/s Khurana Sharma & Co., was also noted and approved.
Independence Confirmation
The company has confirmed that Mrs. Preeti Sarin meets the independence criteria as stipulated by the Companies Act, 2013, and SEBI Listing Regulations. She is not debarred from holding a director’s position by any order from SEBI or any other relevant authority. The disclosure regarding the board meeting’s outcome, as required under SEBI regulations, has been provided.
Source: BSE
